Experience

Leads Biolabs Announces HK$1.29 Billion IPO

July 25, 2025

Cooley advised Nanjing Leads Biolabs Co. (Leads Biolabs), a clinical-stage biotechnology company that discovers, develops and commercializes new therapies in oncology, autoimmune and other severe diseases, on its HK$1.29 billion initial public offering (IPO).

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Kaiting Yang
Counsel, Hong Kong
Yiying Wang
Counsel, Shanghai
Yunxiang Xu
Associate, Shanghai
Brian Lau
Associate, Hong Kong
Alex Wu
Associate, Shanghai
Daniel Zheng
Associate, Shanghai
Zhengyang Li
International Legal Project Manager, Hong Kong
Cindy Pan
International Legal Project Manager, Hong Kong
Zoe Wang
International Legal Project Manager, Shanghai
Xander Lee
Partner, Santa Monica
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Vince Sampson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

VISEN Pharmaceuticals Announces HK$783 Million IPO

March 21, 2025

Cooley advised VISEN Pharmaceuticals, a late-stage, near-commercialization biopharmaceutical company focused on providing treatments for select endocrine diseases in Greater China (including Hong Kong, Macau and Taiwan), on its HK$783 million (approximately US$101 million) initial public offering (IPO) on the Stock Exchange of Hong Kong, subject to the exercise of a 15% overallotment option.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Will Cai
Partner, Hong Kong
Annie Froehlich
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Aaron Pomeroy
Partner, Colorado
Francis Wheeler
Senior Counsel, Colorado
Hilda Li
Associate, Hong Kong
Ying Liu
Associate, Hong Kong
Amanda Pacheco
Associate, Palo Alto
Hardy Zhou
Associate, New York
Alex Wu
Associate, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Kaiting Yang
Counsel, Hong Kong

Related Practices & Industries

Zhejiang Taimei Medical Technology Announces HK$335.1 Million IPO

October 8, 2024

Cooley advised the underwriters of Zhejiang Taimei Medical Technology (Taimei), a digital solution provider focused on the pharmaceutical and medical device industry in China, on its HK$335.1 million initial public offering.

Related contacts

Ethan Jin
Partner, Beijing
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Lisa Yuan
Special Counsel, Beijing
Yiying Wang
Counsel, Shanghai
Mengchao Wu
Associate, Beijing
Shuaiwen Wang
International Legal Project Manager, Beijing
Alex Wu
Associate, Shanghai
Xander Lee
Partner, Santa Monica
Alessandra Murata
Partner, Palo Alto
Francis Wheeler
Senior Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Megan Drill
Associate, San Diego
Rick Jantz
Associate, Santa Monica

Related Practices & Industries

ImmuneOnco Biopharmaceuticals – HK$319 Million IPO

September 5, 2023

Cooley advised ImmuneOnco Biopharmaceuticals, a clinical-stage biotechnology company dedicated to the development of immuno-oncology therapies, on its HK$319 million initial public offering.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Xander Lee
Partner, Santa Monica
Francis Wheeler
Senior Counsel, Colorado
Eric Blanchard
Partner, Boston
Yiying Wang
Counsel, Shanghai
Kaiting Yang
Counsel, Hong Kong
Yunxiang Xu
Associate, Shanghai
Cecilia Bai
Associate , Singapore
Rick Jantz
Associate, Santa Monica
Cindy Pan
International Legal Project Manager, Hong Kong
Alex Wu
Associate, Shanghai
Zhengyang Li
International Legal Project Manager, Hong Kong

Related Practices & Industries

Cryofocus Medtech – HK$210 Million IPO

January 5, 2023

Cooley advised the joint sponsors and underwriters of Cryofocus Medtech’s HK$210 million ($27 million) initial public offering of 11,110,000 H Shares on the Hong Kong Stock Exchange.
Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Will Cai
Partner, Hong Kong
Kaiting Yang
Counsel, Hong Kong
Yiying Wang
Counsel, Shanghai
Yunxiang Xu
Associate, Shanghai
Brian Lau
Associate, Hong Kong
Alex Wu
Associate, Shanghai
Zhengyang Li
International Legal Project Manager, Hong Kong

Admissions and credentials

New York

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.